Sponsor or institution
Clinical trials and research at Fundación Española de Hematología y Hemoterapía
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Fundación Española de Hematología y Hemoterapía that are recruiting, in Spain. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Registry for patients with Primary Immune Thrombocytopenia in Spain | — | A Coruña, A Coruña and 35 other locations | Recruiting | Apr 9, 2025 |
| Prevalence of Acid Sphingomyelinase Deficiency and Gaucher Disease in Patients with Monoclonal Gammopathies | — | Vitoria-Gasteiz, Alava and 22 other locations | Recruiting | Aug 15, 2023 |
| Registry for patients with Thrombotic Thrombocytopenic Purpura in Spain and Portugal | — | Seville, Andalusia and 6 other locations | Recruiting | Jun 22, 2023 |
| Spanish registry of adults with IgM monoclonal gammopathies including Waldenström macroglobulinemia | — | Mérida, Badajoz and 50 other locations | Recruiting | Oct 26, 2021 |
All recruiting trials (4)
-
Registry for patients with Primary Immune Thrombocytopenia in Spain
This study is collecting information from patients with Primary Immune Thrombocytopenia in Spain to better understand the condition and improve how it's treated.
-
Prevalence of Acid Sphingomyelinase Deficiency and Gaucher Disease in Patients with Monoclonal Gammopathies
This study is trying to see how common Acid Sphingomyelinase Deficiency and Gaucher Disease are in patients with monoclonal gammopathies, especially those with an enlarged spleen or who have had their spleen removed.
-
Registry for patients with Thrombotic Thrombocytopenic Purpura in Spain and Portugal
This study is collecting information from at least 300 patients with Thrombotic Thrombocytopenic Purpura in Spain and Portugal to see how well treatments work and to learn more about the condition.
-
Spanish registry of adults with IgM monoclonal gammopathies including Waldenström macroglobulinemia
This registry collects health, disease, and treatment history from adults in Spain with IgM monoclonal gammopathies, including Waldenström macroglobulinemia, to see which treatments lead to better long-term outcomes.
Quick answers
How many clinical trials run by Fundación Española de Hematología y Hemoterapía are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in Spain. Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.